New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19

August 6, 2020

Washington, DC

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today announces the publication of its H1 2020 Global Sector Report, “Innovation in the Time of COVID-19.” The report provides an in-depth look at trends and metrics in the gene, cell, and tissue-based therapeutic sector in the midst of the pandemic.


Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies

July 29, 2020

WASHINGTON, DC and BRUSSELS, BELGIUM


The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020 Cell & Gene Meeting on the Mesa

July 29, 2020

Washington, DC

The Cell & Gene Meeting on the Mesa features presentations by 115+ leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the regenerative medicine sector.


Alliance for Regenerative Medicine Responds to EU Pharmaceutical Roadmap

July 7, 2020

WASHINGTON, DC and BRUSSELS, BELGIUM